Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc.
Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc.
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________
AVANIR PHARMACEUTICALS INC., Plaintiff-Appellee
AVANIR HOLDING COMPANY, CENTER FOR NEUROLOGICAL STUDY, Plaintiffs
v.
PAR PHARMACEUTICAL INC., PAR PHARMACEUTICAL COMPANIES INC., Defendants-Appellants ______________________
2014-1838 ______________________
Appeal from the United States District Court for the District of Delaware in No. 1:11-cv-00704-LPS, Chief Judge Leonard P. Stark. ______________________
JUDGMENT ______________________
F. DOMINIC CERRITO, Quinn Emanuel Urquhart & Sullivan, LLP, New York, NY, argued for plaintiff- appellee. Also represented by ERIC C. STOPS, EVANGELINE SHIH, DANIEL C. WIESNER. JANINE A. CARLAN, Arent Fox, LLP, Washington, DC, argued for defendants-appellants. Also represented by RICHARD J. BERMAN, AZIZ BURGY, TANIEL ERMANO ANDERSON, STEPHEN YANG. ______________________
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (CHEN, LINN, and HUGHES, Circuit Judg- es). AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
August 10, 2015 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court
Reference
- Status
- Unpublished